Ericsson announced on March 2, 2022 that the Department of Justice determined the company failed to comply with a 2019 deferred prosecution agreement for a second time.
This CBM partnership with GTP is focused on moving therapeutics safely and rapidly from concept to clinic by connecting certain of Penn’s established gene therapy platforms with CBM’s manufacturing and analytical capacity.
Several recent events highlight the expanding effort by the federal government to address the growing digital currency marketplace and the government’s role in it.